Complete pathologic response as a prognostic factor for squamous cell carcinoma of the oropharynx post-chemoradiotherapy
Damila Cristina Trufelli(Faculdade de Medicina do ABC), Gilberto de Castro(Instituto do Câncer do Estado de São Paulo), Jossi Ledo Kanda(Faculdade de Medicina do ABC), Auro del Giglio(Faculdade de Medicina do ABC), Fábio de Aquino Capelli(Faculdade de Medicina do ABC), Thaiana Aragão Santana(Faculdade de Medicina do ABC), Leandro Luongo Matos(Faculdade de Medicina do ABC)
Cited by 5
Related Papers
Methylene blue in photodynamic therapy: From basic mechanisms to clinical applications
|Photodiagnosis and Photodynamic Therapy|2005|910
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial
|The Lancet Oncology|2015|394
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non–Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study
|Journal of Clinical Oncology|2022|334
The biology of cancer-related fatigue: a review of the literature
|Supportive Care in Cancer|2015|305